Description
Easily check for possible interactions of nirmatrelvir/ritonavir with different drugs. You can simultaneously search for multiple drugs to see if they can be co-administered, if they should be avoided, or if any additional adjustments are required.
Screenshots
NMV／r FAQ
-
Is NMV／r free?
Yes, NMV／r is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is NMV／r legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does NMV／r cost?
NMV／r is free.
-
What is NMV／r revenue?
To get estimated revenue of NMV／r app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Canada yet.
Ratings History
NMV／r Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
NMV／r Competitors
| Name | Downloads (30d) | Monthly Revenue | Reviews | Ratings | Recent release | |
|---|---|---|---|---|---|---|
SEMES APP
|
Unlock
|
Unlock
|
0
|
|
5 months ago | |
SEFH-Guías práct. farmacéutica
|
Unlock
|
Unlock
|
0
|
|
6 months ago | |
mirSEOM
|
Unlock
|
Unlock
|
0
|
|
9 months ago | |
Instituto ORL IOM
|
Unlock
|
Unlock
|
0
|
|
2 months ago | |
SEOM Congress
|
Unlock
|
Unlock
|
0
|
|
2 months ago | |
Guia Epilepsia SEN
N/A
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
PROA Germans Trias
N/A
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
Interacciones ITC
N/A
|
Unlock
|
Unlock
|
0
|
|
2 years ago | |
N/A
N/A
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
N/A
N/A
|
Unlock
|
Unlock
|
0
|
|
1 year ago |
NMV／r Installs
Last 30 days
NMV／r Revenue
Last 30 daysNMV／r Revenue and Downloads
Gain valuable insights into NMV／r performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
-
GARMENMED, SCP
- Languages
- English, Spanish
- Recent release
- 1.1 (1 year ago )
- Released on
- Aug 30, 2022 (2 years ago )
- Also available in
- Spain , Philippines , Italy , Japan , South Korea , Kuwait , Kazakhstan , Lebanon , Malaysia , Nigeria , Netherlands , Norway , New Zealand , India , Portugal , Romania , Russia , Saudi Arabia , Sweden , Singapore , Thailand , Türkiye , Taiwan , United States , Vietnam , South Africa , Denmark , Argentina , Austria , Azerbaijan , Belarus , Canada , Switzerland , Chile , China , Colombia , Czechia , Germany , United Arab Emirates , Dominican Republic , Algeria , Ecuador , Egypt , Finland , France , United Kingdom , Greece , Hong Kong SAR China , Ireland , Israel
- Last Updated
- 3 weeks ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.